STANFORD, Calif. — One in four people who are chronically infected with hepatitis B will die from its impact if untreated, but a team of researchers at the Stanford University School of Medicine has identified the most cost-effective way of fighting this treacherous infection.Those infected with hepatitis B often don’t know it, because they can go without symptoms for years. Looking at adults in the U.S. group most likely to be infected with hepatitis B—Asians and Pacific Islanders—the Stanford researchers created a mathematical model that found the most effective strategy is to screen this group to identify those who are chronically infected.
